{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:08:17Z","timestamp":1792591697579,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T00:00:00Z","timestamp":1363305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/npp.2013.69","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T16:38:41Z","timestamp":1363365521000},"page":"1625-1635","source":"Crossref","is-referenced-by-count":105,"title":["A Translational Rodent Assay of Affective Biases in Depression and Antidepressant Therapy"],"prefix":"10.1038","volume":"38","author":[{"given":"Sarah A","family":"Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R","family":"Munaf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma SJ","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,15]]},"reference":[{"key":"BFnpp201369_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00213-012-2932-5","volume":"226","author":"MH Anderson","year":"2013","unstructured":"Anderson MH, Munaf\u00f2 MR, Robinson ES (2013). Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology (Berl) 226: 601\u2013613.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201369_CR2","first-page":"221","volume":"36","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J, Fredricson-Overo K (1984). Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions. Pol J Pharmacol Pharm 36: 221\u2013230.","journal-title":"Pol J Pharmacol Pharm"},{"key":"BFnpp201369_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00213-008-1410-6","volume":"203","author":"D Arnone","year":"2009","unstructured":"Arnone D, Horder J, Cowen PJ, Harmer CJ (2009). Early effects of mirtazapine on emotional processing. Psychopharmacology 203: 685\u2013691.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","volume":"19","author":"MT Bardo","year":"1995","unstructured":"Bardo MT, Rowlett JK, Harris MJ (1995). Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19: 39\u201351.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201369_CR5","volume-title":"Depression: Clinical, Experimental, and Theoretical Aspects","author":"AT Beck","year":"1967","unstructured":"Beck AT (1967) Depression: Clinical, Experimental, and Theoretical Aspects. Harper & Row: New York."},{"key":"BFnpp201369_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00213-008-1099-6","volume":"199","author":"KC Berridge","year":"2008","unstructured":"Berridge KC, Kringelbach ML (2008). Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199: 457\u2013480.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.1222940","volume":"338","author":"O Berton","year":"2012","unstructured":"Berton O, Hahn C, Thase ME (2012). Are we getting closer to valid translational models for major depression? Science 338: 75\u201379.","journal-title":"Science"},{"key":"BFnpp201369_CR8","first-page":"126","volume":"29","author":"M Bourin","year":"2004","unstructured":"Bourin M, Moca\u00ebr E, Porsolt R (2004). Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci 29: 126\u2013133.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp201369_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4088\/JCP.10r05993","volume":"73","author":"JD Bremner","year":"2012","unstructured":"Bremner JD, Shearer KD, McCaffery PJ (2012). Retinoic acid and affective disorders: the evidence for an association. J Clin Psychiatry 73: 37\u201350.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp201369_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269881106074062","volume":"21","author":"M Browning","year":"2007","unstructured":"Browning M, Reid C, Cowen PJ, Goodwin GM, Harmer CJ (2007). A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacology 21: 684\u2013690.","journal-title":"J Psychopharmacology"},{"key":"BFnpp201369_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0269881109103101","volume":"24","author":"P Chandra","year":"2010","unstructured":"Chandra P, Hafizi S, Massey-Chase RM, Goodwin GM, Cowen PJ, Harmer CJ (2010). NK1 receptor antagonism and emotional processing in healthy volunteers. J Psychopharmacol 24: 481\u2013487.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201369_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0014-2999(99)00492-6","volume":"379","author":"TJ Connor","year":"1999","unstructured":"Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE (1999). Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. Eur J Pharmacol 379: 125\u2013133.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201369_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrd1825","volume":"4","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Holmes A (2005). The ascent of mouse: advances in modeling human depression and anxiety. Nat Rev Drug Discov 4: 775\u2013790.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp201369_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YCO.0b013e3280117733","volume":"20","author":"JF Cryan","year":"2007","unstructured":"Cryan JF, Slattery DF (2007). Animal models of mood disorders: recent developments. Curr Opin Psychiatry 20: 1\u20137.","journal-title":"Curr Opin Psychiatry"},{"key":"BFnpp201369_CR15","unstructured":"DSM IV (1994) American Psychiatric Association, Diagnostic and statistical manual of mental disorders 4th ed. American Psychiatric Press: Washington DC."},{"key":"BFnpp201369_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/npp.2010.77","volume":"36","author":"R Elliott","year":"2011","unstructured":"Elliott R, Zahn R, Deakin JF, Anderson IM (2011). Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 36: 153\u2013182.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201369_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1527-3458.2007.00025.x","volume":"13","author":"AK Evans","year":"2007","unstructured":"Evans AK, Lowry CA (2007). Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects. CNS Drug Rev 13: 475\u2013501.","journal-title":"CNS Drug Rev"},{"key":"BFnpp201369_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/toxsci\/kfi262","volume":"87","author":"S Ferguson","year":"2005","unstructured":"Ferguson S, Cisneros F, Gough B, Hanig J, Berry K (2005). Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. Toxicol Sci 87: 451\u2013459.","journal-title":"Toxicol Sci"},{"key":"BFnpp201369_CR19","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/archpsyc.61.9.877","volume":"61","author":"CH Fu","year":"2004","unstructured":"Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J et al (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61: 877\u2013889.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201369_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev.clinpsy.121208.131305","volume":"27","author":"IH Gotlib","year":"2010","unstructured":"Gotlib IH, Joormann J (2010). Cognition and depression: current status and future directions. Annu Rev Clin Psychol 27: 285\u2013312.","journal-title":"Annu Rev Clin Psychol"},{"key":"BFnpp201369_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0165-1781(92)90116-K","volume":"42","author":"RC Gur","year":"1992","unstructured":"Gur RC, Erwin RJ, Gur RE, Zwil AS, Heimberg C, Kraemer HC (1992). Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res 42: 241\u2013251.","journal-title":"Psychiatry Res"},{"key":"BFnpp201369_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/427312a","volume":"427","author":"EJ Harding","year":"2004","unstructured":"Harding EJ, Paul ES, Mendl M (2004). Animal behaviour: cognitive bias and affective state. Nature 427: 312.","journal-title":"Nature"},{"key":"BFnpp201369_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/0269881110376689","volume":"25","author":"CJ Harmer","year":"2011","unstructured":"Harmer CJ, de Bodinat C, Dawson GR, Dourish CT, Waldenmaier L, Adams S et al (2011). Agomelatine facilitates positive versus negative affective processing in healthy volunteer models. J Psychopharmacol 25: 1159\u20131167.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201369_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","volume":"195","author":"CJ Harmer","year":"2008","unstructured":"Harmer CJ, Goodwin GM, Cowen PJ (2008). Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195: 102\u2013108.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201369_CR25","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1176\/appi.ajp.160.5.990","volume":"160","author":"CJ Harmer","year":"2003","unstructured":"Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM (2003). Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160: 990\u2013992.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201369_CR26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1176\/appi.ajp.160.5.990","volume":"160","author":"CJ Harmer","year":"2004","unstructured":"Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM (2004). Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160: 990\u2013992.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201369_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1176\/appi.ajp.2009.09020149","volume":"166","author":"CJ Harmer","year":"2009","unstructured":"Harmer CJ, O\u2019Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A et al (2009). Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166: 1178\u20131184.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201369_CR28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1176\/appi.ajp.161.7.1256","volume":"161","author":"CJ Harmer","year":"2004","unstructured":"Harmer CJ, Shelley N, Cowen P, Goodwin G (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161: 1256\u20131263.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201369_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.psyneuen.2008.03.008","volume":"33","author":"C Heim","year":"2008","unstructured":"Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2008). The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33: 693\u2013710.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp201369_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(11)60095-0","volume":"378","author":"IB Hickie","year":"2011","unstructured":"Hickie IB, Rogers NL (2011). Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet 378: 621\u2013631.","journal-title":"Lancet"},{"key":"BFnpp201369_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00213-009-1517-4","volume":"205","author":"J Horder","year":"2009","unstructured":"Horder J, Cowen PJ, Di Simplicio M, Browning M, Harmer CJ (2009). Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology 205: 85\u201391.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0269881112466182","volume":"27","author":"CS Humpston","year":"2013","unstructured":"Humpston CS, Wood CM, Robinson ES (2013). Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task. J Psychopharmacol 27: 213\u2013221.","journal-title":"J Psychopharmacol"},{"key":"BFnpp201369_CR33","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.bcp.2010.12.028","volume":"81","author":"JF Keeler","year":"2011","unstructured":"Keeler JF, Robbins TW (2011). Translating cognition from animals to humans. Biochem Pharmacol 81: 1356\u20131366.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp201369_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/YIC.0b013e32832a8ec8","volume":"24","author":"S Kasper","year":"2009","unstructured":"Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R et al (2009). Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram. Int Clin Psychopharmacol 24: 119\u2013125.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp201369_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","volume":"59","author":"M Keller","year":"2006","unstructured":"Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G et al (2006). Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 59: 216\u2013223.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201369_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn849","volume":"3","author":"JJ Kim","year":"2002","unstructured":"Kim JJ, Diamond DM (2002). The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3: 453\u2013462.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp201369_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.concog.2005.07.005","volume":"15","author":"C Lemogne","year":"2006","unstructured":"Lemogne C, Piolino P, Friszer S, Claret A, Girault N, Jouvent R et al (2006). Episodic autobiographical memory in depression: specificity, autonoetic consciousness, and self perspective. Conscious Cogn 15: 258\u2013268.","journal-title":"Conscious Cogn"},{"key":"BFnpp201369_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.yco.0000191500.46411.00","volume":"19","author":"JM Lepp\u00e4nen","year":"2006","unstructured":"Lepp\u00e4nen JM (2006). Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings. Curr Opin Psychiatry 19: 34\u201339.","journal-title":"Curr Opin Psychiatry"},{"key":"BFnpp201369_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.clinpsy.1.102803.143916","volume":"1","author":"A Mathews","year":"2005","unstructured":"Mathews A, MacLeod C (2005). Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol 1: 167\u2013195.","journal-title":"Annu Rev Clin Psychol"},{"key":"BFnpp201369_CR40","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1098\/rspb.2010.0303","volume":"277","author":"M Mendl","year":"2010","unstructured":"Mendl M, Burman OH, Paul ES (2010). An integrative and functional framework for the study of animal emotion and mood. Proc Biol Sci 277: 2895\u20132904.","journal-title":"Proc Biol Sci"},{"key":"BFnpp201369_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370: 851\u2013858.","journal-title":"Lancet"},{"key":"BFnpp201369_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00213-008-1082-2","volume":"199","author":"SE Murphy","year":"2008","unstructured":"Murphy SE, Downham C, Cowen PJ, Harmer CJ (2008). Direct effects of diazepam on emotional processing in healthy volunteers. Psychopharmacology 199: 503\u2013513.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR43","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE (2010). Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161\u20131169.","journal-title":"Nat Neurosci"},{"key":"BFnpp201369_CR44","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","volume":"31","author":"K O\u2019Reilly","year":"2006","unstructured":"O\u2019Reilly K, Shumake J, Gonzalez-Lima F, Lane MA, Bailey SJ (2006). Chronic administration of 13-cis-retinoic acid enhances depression-related behavior in mice. Neuropsychopharmacology 31: 1919\u20131927.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201369_CR45","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1037\/a0027969","volume":"20","author":"M Papadatou-Pastou","year":"2012","unstructured":"Papadatou-Pastou M, Miskowiak KW, Williams JM, Harmer CJ, Reinecke A (2012). Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study. Exp Clin Psychopharmacol 20: 364\u2013372.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp201369_CR46","doi-asserted-by":"crossref","first-page":"5.9.1","DOI":"10.1002\/0471141755.ph0509s57","volume":"57","author":"M Papp","year":"2012","unstructured":"Papp M (2012). Models of affective illness: chronic mild stress in the rat. Curr Protoc Pharmacol 57: 5.9.1\u20135.9.11.","journal-title":"Curr Protoc Pharmacol"},{"key":"BFnpp201369_CR47","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730\u2013732.","journal-title":"Nature"},{"key":"BFnpp201369_CR48","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.pnpbp.2010.07.022","volume":"35","author":"A Pringle","year":"2011","unstructured":"Pringle A, Browning M, Cowen PJ, Harmer CJ (2011). A cognitive neuropsychological model of antidepressant drug action. Prog Neuropsychopharmacol Biol Psychiatry 35: 1586\u20131592.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp201369_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0166-4328(02)00203-6","volume":"136","author":"JP Reneric","year":"2002","unstructured":"Reneric JP, Bouvard M, Stinus L (2002). In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/Naantidepressant treatments may produce greater effects than selective drugs. Behav Brain Res 136: 521\u2013532.","journal-title":"Behav Brain Res"},{"key":"BFnpp201369_CR50","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nn1944","volume":"10","author":"KJ Ressler","year":"2007","unstructured":"Ressler KJ, Mayberg HS (2007). Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10: 1116\u20131124.","journal-title":"Nat Neurosci"},{"key":"BFnpp201369_CR51","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00213-011-2420-3","volume":"219","author":"ES Robinson","year":"2012","unstructured":"Robinson ES (2012). Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks. Psychopharmacology (Berl) 219: 303\u2013312.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201369_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0091-3057(95)00190-8","volume":"52","author":"RJ Rogers","year":"1995","unstructured":"Rogers RJ, Cole JC, Aboualfa K, Stephenson LH (1995). Ethopharmacological analysis of the effects of putative \u2018anxiogenic\u2019 agents in the mouse. Pharmacol Biochem Behav 52: 805\u2013813.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201369_CR53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/npp.2011.183","volume":"37","author":"JP Roiser","year":"2012","unstructured":"Roiser JP, Elliott R, Sahakian BJ (2012). Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37: 117\u2013136.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201369_CR54","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/jama.299.13.1601","volume":"299","author":"JS Rumsfeld","year":"2008","unstructured":"Rumsfeld JS, Nallamothu BK (2008). The hope and fear of rimonabant. JAMA 299: 1601\u20131602.","journal-title":"JAMA"},{"key":"BFnpp201369_CR55","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0091-3057(95)02102-7","volume":"53","author":"RB Stewart","year":"1996","unstructured":"Stewart RB, Murphy JM, McBride WJ, Lumeng L, Li TK (1996). Place conditioning with alcohol in alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 53: 487\u2013491.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201369_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.biopsych.2004.10.028","volume":"57","author":"S Surguladze","year":"2005","unstructured":"Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ et al (2005). A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57: 201\u2013209.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201369_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"T Tzavara","year":"2003","unstructured":"Tzavara T, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP et al (2003). The CB1 receptor antagonist SR141716A selectively increases monaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138: 544\u2013553.","journal-title":"Br J Pharmacol"},{"key":"BFnpp201369_CR58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archgenpsychiatry.2009.50","volume":"66","author":"SA Vreeburg","year":"2009","unstructured":"Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R et al (2009). Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 66: 617\u2013626.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201369_CR59","first-page":"191","volume":"33","author":"TL Wallace-Boone","year":"2007","unstructured":"Wallace-Boone TL, Newton AE, Wright RN, Lodge NL, McElroy JF (2007). Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists. Neuropsychopharmacology 33: 191\u2013192.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201369_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-012-2708-y","volume":"223","author":"MC Wardle","year":"2012","unstructured":"Wardle MC, Garner MJ, Munaf\u00f2 MR, de Wit H (2012). Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology 223: 199\u2013210.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1037\/0021-843X.105.1.34","volume":"105","author":"PC Watkins","year":"1996","unstructured":"Watkins PC, Vache K, Vernay SP, Muller S, Mathews A (1996). Unconscious mood-congruent memory bias in depression. J Abnormal Psychol 105: 34\u201341.","journal-title":"J Abnormal Psychol"},{"key":"BFnpp201369_CR62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF02244228","volume":"101","author":"S Wieland","year":"1990","unstructured":"Wieland S, Lucki I (1990). Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology 101: 497\u2013504.","journal-title":"Psychopharmacology"},{"key":"BFnpp201369_CR63","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1755-5949.2010.00207.x","volume":"17","author":"K Wingenfeld","year":"2011","unstructured":"Wingenfeld K, Wolf OT (2011). HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions. CNS Neurosci Ther 17: 714\u2013722.","journal-title":"CNS Neurosci Ther"},{"key":"BFnpp201369_CR64","first-page":"171","volume":"2","author":"DT Wong","year":"1990","unstructured":"Wong DT, Fuller RW, Robertson DW (1990). Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. Acta Pharm Nord 2: 171\u2013180.","journal-title":"Acta Pharm Nord"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:24Z","timestamp":1684453644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,15]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnpp201369"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.69","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,15]]}}}